These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36504724)

  • 1. Beneficial effects of bempedoic acid treatment in polycystic kidney disease cells and mice.
    Hallows KR; Li H; Saitta B; Sepehr S; Huang P; Pham J; Wang J; Mancino V; Chung EJ; Pinkosky SL; Pastor-Soler NM
    Front Mol Biosci; 2022; 9():1001941. PubMed ID: 36504724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bempedoic Acid Unveils Therapeutic Potential in Non-Alcoholic Fatty Liver Disease: Suppression of the Hepatic PXR-SLC13A5/ACLY Signaling Axis.
    Sun Q; Guo Y; Hu W; Zhang M; Wang S; Lei Y; Meng H; Li N; Xu P; Li Z; Lin H; Huang F; Qiu Z
    Drug Metab Dispos; 2023 Dec; 51(12):1628-1641. PubMed ID: 37684055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bempedoic acid, an ATP citrate lyase inhibitor, reduces intimal hyperplasia via activation of AMPKα signaling pathway.
    Liu W; Liu M; Xiong H; Xia L; Yang Q; Chen M; Cai Y; Li S
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109392. PubMed ID: 36461594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolvaptan inhibits ERK-dependent cell proliferation, Cl⁻ secretion, and in vitro cyst growth of human ADPKD cells stimulated by vasopressin.
    Reif GA; Yamaguchi T; Nivens E; Fujiki H; Pinto CS; Wallace DP
    Am J Physiol Renal Physiol; 2011 Nov; 301(5):F1005-13. PubMed ID: 21816754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of the novel ACLY inhibitor 326E as a promising treatment for hypercholesterolemia.
    Xie Z; Zhang M; Song Q; Cheng L; Zhang X; Song G; Sun X; Gu M; Zhou C; Zhang Y; Zhu K; Yin J; Chen X; Li J; Nan F
    Acta Pharm Sin B; 2023 Feb; 13(2):739-753. PubMed ID: 36873173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical evaluation of tolvaptan and salsalate combination therapy in a
    Song X; Leonhard WN; Kanhai AA; Steinberg GR; Pei Y; Peters DJM
    Front Mol Biosci; 2023; 10():1058825. PubMed ID: 36743216
    [No Abstract]   [Full Text] [Related]  

  • 7. Steviol retards renal cyst growth through reduction of CFTR expression and inhibition of epithelial cell proliferation in a mouse model of polycystic kidney disease.
    Yuajit C; Muanprasat C; Gallagher AR; Fedeles SV; Kittayaruksakul S; Homvisasevongsa S; Somlo S; Chatsudthipong V
    Biochem Pharmacol; 2014 Apr; 88(3):412-21. PubMed ID: 24518257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TOLVAPTAN USE IN SEVERE NEONATAL AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD): THE PHARMACEUTICAL CHALLENGE.
    Olalekan K; Fox A; Gilbert R
    Arch Dis Child; 2016 Sep; 101(9):e2. PubMed ID: 27540244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATP-citrate lyase (ACLY) in lipid metabolism and atherosclerosis: An updated review.
    Feng X; Zhang L; Xu S; Shen AZ
    Prog Lipid Res; 2020 Jan; 77():101006. PubMed ID: 31499095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aquaporin-3 deficiency slows cyst enlargement in experimental mouse models of autosomal dominant polycystic kidney disease.
    Wang W; Geng X; Lei L; Jia Y; Li Y; Zhou H; Verkman AS; Yang B
    FASEB J; 2019 May; 33(5):6185-6196. PubMed ID: 30768374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tolvaptan, a vasopressin V
    Yamada Y; Fujiki H; Mizuguchi H; Takeshita Y; Hattori K; Ohmoto K; Aihara M; Nagano K; Isakari Y; Yamamoto M; Yamamura Y
    Nihon Yakurigaku Zasshi; 2022; 157(4):254-260. PubMed ID: 35781456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of Basolateral Targeting Micelles for Drug Delivery Applications in Polycystic Kidney Disease.
    Huang Y; Osouli A; Pham J; Mancino V; O'Grady C; Khan T; Chaudhuri B; Pastor-Soler NM; Hallows KR; Chung EJ
    Biomacromolecules; 2024 May; 25(5):2749-2761. PubMed ID: 38652072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Manifestation and Management of ADPKD in Western Countries.
    Sommerer C; Zeier M
    Kidney Dis (Basel); 2016 Oct; 2(3):120-127. PubMed ID: 27921039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamine metabolism via glutaminase 1 in autosomal-dominant polycystic kidney disease.
    Soomro I; Sun Y; Li Z; Diggs L; Hatzivassiliou G; Thomas AG; Rais R; Parker SJ; Slusher BS; Kimmelman AC; Somlo S; Skolnik EY
    Nephrol Dial Transplant; 2018 Aug; 33(8):1343-1353. PubMed ID: 29420817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the timing and magnitude of Pkd1 gene deletion determine the severity of polycystic kidney disease in an orthologous mouse model of ADPKD.
    Rogers KA; Moreno SE; Smith LA; Husson H; Bukanov NO; Ledbetter SR; Budman Y; Lu Y; Wang B; Ibraghimov-Beskrovnaya O; Natoli TA
    Physiol Rep; 2016 Jun; 4(12):. PubMed ID: 27356569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATP citrate lyase knockdown induces growth arrest and apoptosis through different cell- and environment-dependent mechanisms.
    Zaidi N; Royaux I; Swinnen JV; Smans K
    Mol Cancer Ther; 2012 Sep; 11(9):1925-35. PubMed ID: 22718913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bempedoic acid: effects on lipoprotein metabolism and atherosclerosis.
    Burke AC; Telford DE; Huff MW
    Curr Opin Lipidol; 2019 Feb; 30(1):1-9. PubMed ID: 30586346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of ATP citrate lyase induces an anticancer effect via reactive oxygen species: AMPK as a predictive biomarker for therapeutic impact.
    Migita T; Okabe S; Ikeda K; Igarashi S; Sugawara S; Tomida A; Taguchi R; Soga T; Seimiya H
    Am J Pathol; 2013 May; 182(5):1800-10. PubMed ID: 23506848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining Metformin and Drug-Loaded Kidney-Targeting Micelles for Polycystic Kidney Disease.
    Jiang K; Huang Y; Chung EJ
    Cell Mol Bioeng; 2023 Feb; 16(1):55-67. PubMed ID: 36660586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triptolide reduces cyst formation in a neonatal to adult transition Pkd1 model of ADPKD.
    Leuenroth SJ; Bencivenga N; Chahboune H; Hyder F; Crews CM
    Nephrol Dial Transplant; 2010 Jul; 25(7):2187-94. PubMed ID: 20139063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.